This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
golgi apparatus | 73 |
signal sequence | 64 |
reading frame | 50 |
golgl apparatus | 49 |
angiotensinogen mrna | 36 |
cell surface | 33 |
immature vesicles | 32 |
infected cells | 31 |
frameshift site | 31 |
botulinum toxin | 27 |
nucleotide sequence | 27 |
plasma membrane | 27 |
sendai virus | 26 |
rats exposed | 25 |
bag cell | 24 |
amino acid | 24 |
respiratory tract | 23 |
class ii | 23 |
necrotizing enterocolitis | 23 |
bone marrow | 23 |
gamma radiation | 22 |
table i | 21 |
pseudomonas aeruginosa | 21 |
bag cells | 19 |
spasmodic torticollis | 19 |
translational pause | 19 |
escherichia coli | 18 |
small immature | 18 |
monoclonal antibodies | 18 |
doc id | 18 |
cord uid | 18 |
mg ada | 18 |
forest virus | 17 |
time point | 17 |
xho i | 16 |
cells infected | 16 |
initiation codon | 16 |
male rats | 15 |
clear vesicles | 15 |
birth weight | 15 |
virus infection | 15 |
reading frames | 15 |
marrow transplantation | 15 |
time points | 15 |
large immature | 15 |
ty elements | 15 |
semliki forest | 14 |
side effects | 14 |
spleen cells | 14 |
ribosomal frameshifting | 14 |
sla class | 14 |
immune globulin | 14 |
viral antigen | 14 |
northern blot | 14 |
amino acids | 13 |
frameshift event | 13 |
nucleotide frameshift | 13 |
secretory pathway | 13 |
striated muscle | 13 |
acid phosphatase | 13 |
week study | 13 |
cuu codon | 13 |
terminal intermediate | 13 |
er membrane | 13 |
cl response | 13 |
bovine coronavirus | 12 |
whole blood | 12 |
upper airway | 12 |
influenza virus | 12 |
cell fusion | 12 |
coding region | 12 |
western blot | 12 |
upper respiratory | 12 |
tissue culture | 11 |
apparatus clsternae | 11 |
gene expression | 11 |
basic study | 11 |
diagnostic reagents | 11 |
interstitial pneumonia | 11 |
transmissible gastroenteritis | 11 |
cell line | 11 |
herpes simplex | 11 |
chain translocation | 11 |
low birth | 10 |
termination codons | 10 |
ards patients | 10 |
agg codon | 10 |
open reading | 10 |
focal dystonia | 10 |
cell lines | 10 |
mg kg | 10 |
ifn production | 10 |
mice exposed | 10 |
immature dcvs | 10 |
kg body | 10 |
membrane proteins | 10 |
infectious agents | 10 |
electron microscopy | 10 |
control group | 10 |
female rats | 10 |
initial cleavage | 10 |
apparatus cisternae | 9 |
blot analysis | 9 |
terminal body | 9 |
toxicology studies | 9 |
weight infants | 9 |
exposure group | 9 |
breast milk | 9 |
bfs cells | 9 |
large vesicles | 9 |
elh prohormone | 9 |
hbv dna | 9 |
acid sequence | 9 |
ha antigens | 9 |
structural proteins | 9 |
simplex virus | 9 |
angiotensinogen gene | 9 |
toxic oxygen | 9 |
secretory vesicles | 9 |
results suggest | 9 |
immune system | 9 |
body weights | 9 |
trna genes | 9 |
experimental procedures | 9 |
infectious diseases | 8 |
adoptive transfer | 8 |
may also | 8 |
acidic compartments | 8 |
ifn induction | 8 |
induced demyelination | 8 |
mhc class | 8 |
cultured cells | 8 |
antibodies directed | 8 |
wide range | 8 |
positive sera | 8 |
pulse plus | 8 |
present study | 8 |
alveolar macrophages | 8 |
fusion proteins | 8 |
irradiated mice | 8 |
membrane protein | 8 |
leucine codons | 8 |
gastrointestinal tract | 8 |
body weight | 8 |
nasal cavity | 8 |
codons downstream | 8 |
ada exposure | 8 |
liver angiotensinogen | 8 |
nylon wool | 8 |
cytotoxin gene | 8 |
secretory proteins | 8 |
standard deviation | 8 |
mrna sequences | 8 |
table ii | 8 |
monensin block | 8 |
rain pulse | 8 |
clinical signs | 8 |
study group | 8 |
kindly provided | 8 |
hepatitis virus | 8 |
viral infections | 8 |
vitro transcription | 8 |
acz gene | 8 |
min pulse | 8 |
i site | 8 |
gel electrophoresis | 8 |
oxygen metabolites | 8 |
carboxy terminal | 8 |
dna binding | 7 |
gastroenteritis virus | 7 |
small intestine | 7 |
bcv antigen | 7 |
monoclonal antibody | 7 |
infected bfs | 7 |
lymph nodes | 7 |
viral replication | 7 |
exposure concentration | 7 |
time course | 7 |
oral iga | 7 |
three codons | 7 |
portal vein | 7 |
two codons | 7 |
ada deposited | 7 |
molecular weight | 7 |
glycosylation site | 7 |
risk factors | 7 |
control infants | 7 |
protein synthesis | 7 |
aug codon | 7 |
ii mab | 7 |
chain synthesis | 7 |
embryonated eggs | 7 |
frameshift sites | 7 |
two groups | 7 |
gamma irradiation | 7 |
treated infants | 7 |
cell monolayers | 7 |
animal cells | 7 |
inoculated sows | 7 |
primary structure | 7 |
minimal sequence | 7 |
fetal sheep | 7 |
termination codon | 7 |
cell cultures | 7 |
kidney cells | 7 |
hemorrhagic gastroenteritis | 7 |
may occur | 7 |
dense core | 7 |
intestinal mucosa | 6 |
stacked cisternae | 6 |
recipient mice | 6 |
cell clusters | 6 |
fetal rat | 6 |
second codon | 6 |
uninoculated sows | 6 |
fold decrease | 6 |
igg preparation | 6 |
laying hormone | 6 |
lysosomal enzymes | 6 |
host cell | 6 |
trans golgi | 6 |
coated vesicles | 6 |
vitro translation | 6 |
proteolytic processing | 6 |
marrow transplant | 6 |
outer membrane | 6 |
several hours | 6 |
plasmid pmb | 6 |
cmv pneumonia | 6 |
endoplasmic reticulum | 6 |
low concentrations | 6 |
polymorphonuclear leukocytes | 6 |
lung lesions | 6 |
bamhl site | 6 |
colloidal gold | 6 |
chemiluminescence response | 6 |
golgi network | 6 |
frameshifting occurs | 6 |
antibody titers | 6 |
acid residues | 6 |
oxalic acid | 6 |
monensin poisoning | 6 |
small mature | 6 |
oral administration | 6 |
frameshift reporter | 6 |
chain transfer | 6 |
human ipc | 6 |
epithelial cells | 6 |
tgev seropositive | 6 |
min sample | 6 |
secondary structure | 6 |
coding sequence | 6 |
dose group | 6 |
inhalation exposure | 6 |
litters born | 6 |
signal peptide | 6 |
mouse hepatitis | 6 |
supernatant fraction | 6 |
subclass deficiency | 6 |
microsomal membranes | 6 |
transplant recipients | 6 |
em autoradiography | 6 |
plasma membranes | 6 |
immune response | 6 |
patients developed | 6 |
endothelial cells | 6 |
pcp dhfr | 6 |
dhfr hybrid | 6 |
generalized dystonia | 6 |
reporter plasmid | 6 |
demyelinating disease | 6 |
sucking piglets | 6 |
rcv sda | 6 |
gene products | 6 |
orally administered | 6 |
whole body | 6 |
nervous system | 6 |
low levels | 6 |
electron microscope | 6 |
chemical co | 6 |
coeliac artery | 6 |
minimal region | 5 |
acetate buffer | 5 |
rat liver | 5 |
sdav infection | 5 |
elh precursor | 5 |
breast feeding | 5 |
mononuclear cells | 5 |
three years | 5 |
plant cells | 5 |
monensln poisoning | 5 |
simultaneous slippage | 5 |
weight gain | 5 |
dense cores | 5 |
quantum yield | 5 |
human milk | 5 |
mean terminal | 5 |
respiratory epithelium | 5 |
pgem alphagx | 5 |
large dcvs | 5 |
clinical score | 5 |
histological scores | 5 |
serum samples | 5 |
blood mononuclear | 5 |
exposure days | 5 |
fusion protein | 5 |
regulated secretory | 5 |
per kg | 5 |
fluorescence intensity | 5 |
baby hamster | 5 |
toxin injections | 5 |
central nervous | 5 |
nucleotide minimal | 5 |
previously shown | 5 |
dna fragment | 5 |
reverse transcriptase | 5 |
polypeptide chain | 5 |
i think | 5 |
connective tissue | 5 |
fetal life | 5 |
host disease | 5 |
per stack | 5 |
mature vesicles | 5 |
total number | 5 |
distress syndrome | 5 |
kd protein | 5 |
xenobiotic metabolism | 5 |
terminal portion | 5 |
ml test | 5 |
idiopathic spasmodic | 5 |
several studies | 5 |
results indicate | 5 |
acid ionophores | 5 |
bf sha | 5 |
lower respiratory | 5 |
hamster kidney | 5 |
viral proteins | 5 |
acute gvhd | 5 |
four glycosylation | 5 |
type sequence | 5 |
days prior | 5 |
prcv inoculated | 5 |
recent studies | 5 |
standard deviations | 5 |
toxicology research | 5 |
depletion experiments | 5 |
viral antigens | 5 |
infected patients | 5 |
translation continues | 5 |
small dcvs | 5 |
terminal region | 5 |
alveolar neutrophils | 5 |
sindbis virus | 5 |
mouse units | 5 |
slippery sequence | 5 |
amino terminal | 5 |
radiation required | 5 |
immune globulins | 5 |
membrane preparations | 5 |
mm edta | 5 |
respiratory distress | 5 |
epithelial necrosis | 5 |
ng ml | 5 |
three reading | 5 |
viral genome | 5 |
chemically induced | 5 |
linked immunosorbent | 5 |
respiratory disease | 5 |
monensin effects | 5 |
membrane glycoproteins | 5 |
lamina propria | 5 |
histocompatibility complex | 5 |
apparatus function | 5 |
vitro synthesized | 5 |
body wt | 5 |
across membranes | 5 |
female mice | 5 |
proteolytic cleavage | 5 |
serum levels | 5 |
treatment group | 5 |
final concentration | 5 |
ehrlich ascites | 5 |
hr postinfection | 5 |
body irradiation | 5 |
sigma chemical | 5 |
biologically active | 5 |
postengraftment phase | 5 |
mrna expression | 5 |
low availability | 5 |
sequence analysis | 5 |
igg treatment | 5 |
major histocompatibility | 5 |
described previously | 5 |
infected mice | 5 |
sorting within | 5 |
codons recognized | 5 |
viral titers | 5 |
closely related | 5 |
hepatoma cells | 5 |
hcmv early | 5 |
incompletely processed | 5 |
biological systems | 5 |
ii antigens | 5 |
taken together | 4 |
barn hi | 4 |
protein sequence | 4 |
dhfr chains | 4 |
neonatal necrotizing | 4 |
animal species | 4 |
blood products | 4 |
naturally occurring | 4 |
well documented | 4 |
exposure groups | 4 |
total cellular | 4 |
complement fixation | 4 |
hcmv infections | 4 |
trna slippage | 4 |
trans golgl | 4 |
highest exposure | 4 |
radiation inactivation | 4 |
rabbit anti | 4 |
synthetic oligonucleotides | 4 |
week studies | 4 |
mycoplasmal infections | 4 |
labeled antisense | 4 |
balb cj | 4 |
renal angiotensinogen | 4 |
proton gradients | 4 |
des cellules | 4 |
carrot cells | 4 |
surface glycoproteins | 4 |
repetitive dna | 4 |
cell types | 4 |
nonstructural proteins | 4 |
sequence region | 4 |
positive cells | 4 |
terminal amino | 4 |
viral glycoprotein | 4 |
narl site | 4 |
occurnng acid | 4 |
target organ | 4 |
igg feeding | 4 |
immunosorbent assay | 4 |
atrial gland | 4 |
golg apparatus | 4 |
dihydrofolate reductase | 4 |
high levels | 4 |
producer cells | 4 |
presumably due | 4 |
inhalation studies | 4 |
pc dhfr | 4 |
i fragment | 4 |
unmodified uracil | 4 |
translation mixtures | 4 |
newborn liver | 4 |
cell replication | 4 |
treated cells | 4 |
week subchronic | 4 |
swollen clsternae | 4 |
normal levels | 4 |
citrated blood | 4 |
cell peptide | 4 |
viral infection | 4 |
binding properties | 4 |
total amount | 4 |
respiratory coronavirus | 4 |
vesicular traffic | 4 |
human serum | 4 |
buffered saline | 4 |
prcv tgev | 4 |
transcription translation | 4 |
two stillborn | 4 |
commonly found | 4 |
control preparations | 4 |
statistically significant | 4 |
porcine ifna | 4 |
gene product | 4 |
murine coronavirus | 4 |
sucrose cushion | 4 |
product peptides | 4 |
cell neurons | 4 |
codon usage | 4 |
animal models | 4 |
seropositive recipients | 4 |
cytopathic effects | 4 |
high sensitivity | 4 |
glycosylation sites | 4 |
ata addition | 4 |
inflammatory cells | 4 |
car bacillus | 4 |
kidney cortex | 4 |
endocytic vesicles | 4 |
dna probes | 4 |
translation rate | 4 |
virus strain | 4 |
dengue virus | 4 |
rabbit reticulocyte | 4 |
immature granules | 4 |
controlled trial | 4 |
fed infants | 4 |
membrane anchor | 4 |
often near | 4 |
sialodacryoadenitis virus | 4 |
plaque formation | 4 |
exposure times | 4 |
gold particles | 4 |
monkey kidney | 4 |
secretory iga | 4 |
cellular rna | 4 |
daily living | 4 |
week repeated | 4 |
antigenic regions | 4 |
direct effect | 4 |
polymerase chain | 4 |
virus type | 4 |
missense mutagenesis | 4 |
von heijne | 4 |
actin mrna | 4 |
autologous transplants | 4 |
abnormal clinical | 4 |
unpublished data | 4 |
polyether antibiotics | 4 |
plasmid pgem | 4 |
galactosidase activity | 4 |
wool nonadherent | 4 |
virus replication | 4 |
pgem dhfrx | 4 |
angiotensin i | 4 |
phosphate buffered | 4 |
goigi apparatus | 4 |
co i | 4 |
mg ml | 4 |
producing cells | 4 |
per cell | 4 |
become glycosylated | 4 |
subchronic study | 4 |
donor mice | 4 |
dna sequences | 4 |
binding sites | 4 |
mab used | 4 |
blot hybridization | 4 |
splenius capitis | 4 |
public health | 4 |
proteins across | 4 |
year period | 4 |
bhk cells | 4 |
infectious virus | 4 |
newcastle disease | 4 |
hungry codons | 4 |
done using | 4 |
applied biosystems | 4 |
plus complement | 4 |
given pfu | 4 |
cytoplasmic fluorescence | 4 |
toxic effects | 4 |
infectivity titers | 4 |
lipid bilayer | 4 |
cytoplasmic vacuolation | 4 |
adult respiratory | 4 |
nonsense codon | 4 |
trans clsternae | 4 |
laboratory animal | 4 |
aspergillus rhinitis | 4 |
naturally occurnng | 4 |
two different | 4 |
liver weights | 4 |
one patient | 4 |
cytopathic effect | 4 |
adoptive transfers | 4 |
spinal cord | 4 |
clinical observations | 4 |
pellet fraction | 4 |
frameshift sequence | 4 |
hiv infection | 4 |
sodium ions | 4 |
neutralizing antibody | 4 |
total rna | 4 |
golga apparatus | 4 |
mm tris | 4 |
nucleocapsid protein | 4 |
beneficial effect | 4 |
per day | 4 |
pgem dhfr | 4 |
frameshift events | 4 |
virus particles | 4 |
peripheral blood | 4 |
min chase | 4 |
cellular responses | 4 |
anterior pituitary | 4 |
pregnant sows | 4 |
frame specific | 4 |
monensm concentrations | 4 |
contact prophylaxis | 4 |
cell turnover | 4 |
golgi stacks | 4 |
oxygen derived | 4 |
human mononuclear | 4 |
reactive oxygen | 4 |
murine pathogens | 4 |
wobble position | 4 |
squamous metaplasia | 4 |
molecular cloning | 4 |
rare trna | 4 |
eco ri | 4 |
molecular basis | 4 |
viral protein | 4 |
processing intermediates | 4 |
edman degradation | 4 |
lymph node | 4 |
membrane glycoprotein | 4 |
monensin treatment | 4 |
viral membrane | 4 |
influenza viruses | 4 |
salivary glands | 4 |
premature infants | 4 |
chain reaction | 4 |
cultured human | 4 |
virus proteins | 4 |
important role | 4 |
specific cytotoxic | 4 |
significant differences | 4 |
respiratory mycoplasmosis | 4 |
signal peptides | 4 |
well understood | 4 |
chronic gvhd | 4 |
na acetate | 4 |
tool test | 3 |
multivesicular bodies | 3 |
dcvs contain | 3 |
reaction product | 3 |
neuraminidase assay | 3 |
na reading | 3 |
outer surface | 3 |
immunoprotective effect | 3 |
translocation across | 3 |
biological membranes | 3 |
another one | 3 |
previously described | 3 |
inactivated influenza | 3 |
developed nec | 3 |
essential medium | 3 |
different viruses | 3 |
individual eggs | 3 |
chronic respiratory | 3 |
fetal liver | 3 |
mdck cells | 3 |
reasonably well | 3 |
lung weights | 3 |
kpnl sites | 3 |
capitis muscles | 3 |
core vesicles | 3 |
food consumption | 3 |
every weeks | 3 |
late golgi | 3 |
neuraminidase activity | 3 |
infectious complications | 3 |
perivascular cuffs | 3 |
immune donors | 3 |
immunoelectron microscopy | 3 |
pg aliquots | 3 |
may become | 3 |
nucleotide binding | 3 |
human lymphocytes | 3 |
consensus sequence | 3 |
sialic acid | 3 |
hybridized filter | 3 |
enhanced chemiluminescence | 3 |
bovine serum | 3 |
globulin administration | 3 |
endoproteolytic cleavage | 3 |
coronavirus glycoprotein | 3 |
golgi complex | 3 |
atomic energy | 3 |
influenza antigens | 3 |
well established | 3 |
coding strand | 3 |
golgi compartment | 3 |
nonabundant trnas | 3 |
even though | 3 |
virus penetration | 3 |
model predicts | 3 |
clsterna per | 3 |
frame slippage | 3 |
bovine fetal | 3 |
min incubation | 3 |
ascites tumor | 3 |
produce interferon | 3 |
necrotising pancreatitis | 3 |
binding site | 3 |
within two | 3 |
positive titers | 3 |
terminal part | 3 |
years storage | 3 |
nan sha | 3 |
dhfr protein | 3 |
gives rise | 3 |
affects primarily | 3 |
nasal epithelial | 3 |
central role | 3 |
propylene oxide | 3 |
induction process | 3 |
experiments using | 3 |
transplacental transmission | 3 |
nan title | 3 |
molecular pathways | 3 |
adverse effects | 3 |
viral glycoproteins | 3 |
uga codon | 3 |
well known | 3 |
mainly based | 3 |
cellular function | 3 |
specific cleavage | 3 |
antibody prevalence | 3 |
nco i | 3 |
membrane interface | 3 |
direct viral | 3 |
transferred i | 3 |
final product | 3 |
bp downstream | 3 |
white matter | 3 |
membrane receptor | 3 |
segmental dystonia | 3 |
coronavirus infection | 3 |
enzyme activity | 3 |
rat kidney | 3 |
endothelial cell | 3 |
nearest competitor | 3 |
immunoglobulin levels | 3 |
underlined values | 3 |
i labeled | 3 |
rodent bioassays | 3 |
ivig might | 3 |
health service | 3 |
high solubility | 3 |
statistical analysis | 3 |
antibody titres | 3 |
subcellular vesicular | 3 |
pge concentration | 3 |
translocated across | 3 |
three sows | 3 |
coding sequences | 3 |
pgem alphag | 3 |
inhalation exposures | 3 |
rheumatic diseases | 3 |
sp promoter | 3 |
rumen rmcroflora | 3 |
freely soluble | 3 |
completely inhibited | 3 |
interferon alpha | 3 |
days per | 3 |
oxygen radical | 3 |
newly synthesized | 3 |
signal recognition | 3 |
flow rate | 3 |
first three | 3 |
alpha interferon | 3 |
nonpolar hydrocarbon | 3 |
lethal dose | 3 |
abundance trna | 3 |
spread acceptance | 3 |
vaginal cytology | 3 |
collapsing na | 3 |
trna gene | 3 |
old male | 3 |
surface antigen | 3 |
surface expression | 3 |
effects observed | 3 |
seronegative recipients | 3 |
reduced ifn | 3 |
highly conserved | 3 |
troublesome side | 3 |
different time | 3 |
field isolates | 3 |
pause induced | 3 |
gamma inactivation | 3 |
cellular response | 3 |
naive donors | 3 |
different stimuli | 3 |
even greater | 3 |
fecal samples | 3 |
transmission electron | 3 |
may remain | 3 |
respiratory syncytial | 3 |
translation system | 3 |
one female | 3 |
two days | 3 |
release factor | 3 |
study male | 3 |
high resolution | 3 |
thin sections | 3 |
solid phase | 3 |
composed largely | 3 |
messenger rna | 3 |
exposure chamber | 3 |
jhmv pathogenesis | 3 |
molecular mass | 3 |
two distinct | 3 |
cell culture | 3 |
short exposure | 3 |
reticulocyte lysate | 3 |
lipid components | 3 |
located within | 3 |
several reports | 3 |
binding proteins | 3 |
alkaline phosphatase | 3 |
cholinesterase activity | 3 |
protein bodies | 3 |
dose groups | 3 |
reversible action | 3 |
relatively high | 3 |
inhaled azodicarbonamide | 3 |
pooled human | 3 |
ii molecules | 3 |
guinea pigs | 3 |
pl sfv | 3 |
enzyme secretion | 3 |
host animal | 3 |
virus membrane | 3 |
transformed cell | 3 |
pseudoknot structure | 3 |
fhua receptor | 3 |
processed molecules | 3 |
yeast ty | 3 |
endocytlc vesicles | 3 |
occurs within | 3 |
intestinal tract | 3 |
preengraftment phase | 3 |
gastrointestinal infection | 3 |
less well | 3 |
radical production | 3 |
cl quantum | 3 |
previously demonstrated | 3 |
responder pbmc | 3 |
day postinfection | 3 |
cohn fraction | 3 |
inactivated virus | 3 |
sea water | 3 |
little tendency | 3 |
infant formula | 3 |
lactate dehydrogenase | 3 |
normally occur | 3 |
rain chase | 3 |
two separate | 3 |
western blots | 3 |
indirect immunofluorescence | 3 |
class i | 3 |
intracellular transport | 3 |
lesser extent | 3 |
virus isolation | 3 |
nylon filter | 3 |
late pregnancy | 3 |
cardiac myocyte | 3 |
gestational age | 3 |
oxalate solution | 3 |
treated bag | 3 |
genetic loci | 3 |
fold increase | 3 |
new england | 3 |
fold lower | 3 |
viral diseases | 3 |
igm antibodies | 3 |
glycosylation machinery | 3 |
pig kidney | 3 |
may cause | 3 |
serial sections | 3 |
workers showed | 3 |
male mice | 3 |
terminal end | 3 |
twice daily | 3 |
trans faces | 3 |
three litters | 3 |
fixed cell | 3 |
dhfr hybrids | 3 |
ribosomal frameshift | 3 |
strain jhm | 3 |
leukemia virus | 3 |
ca accumulation | 3 |
membrane exchange | 3 |
functional role | 3 |
calf serum | 3 |
perinatal complications | 3 |
tumor cells | 3 |
negative cells | 3 |
asw plus | 3 |
amerlite research | 3 |
years age | 3 |
research luminometer | 3 |
myocyte degeneration | 3 |
pvu i | 3 |
mg per | 3 |
immediately upstream | 3 |
codon allows | 3 |
chain elongation | 3 |
without affecting | 3 |
labeled material | 3 |
corona virus | 3 |
newborn lamb | 3 |
residue peptide | 3 |
aerosol concentration | 3 |
peak maximum | 3 |
porcine ipc | 3 |
page sample | 3 |
also play | 3 |
sample buffer | 3 |
copy number | 3 |
per se | 3 |
secretory granules | 3 |
release ca | 3 |
defense mechanisms | 3 |
aqueous membrane | 3 |
type ii | 3 |
retroviral frameshift | 3 |
hbv variants | 3 |
pc alphag | 3 |
commercial value | 3 |
newborn calves | 3 |
i i | 3 |
rabbit serum | 3 |
guinea pig | 3 |
negative bacteria | 3 |
jhmv strains | 3 |
equine encephalitis | 3 |
spasmodic dysphonia | 3 |
hindiii dna | 3 |
gross lesions | 3 |
intracellular compartments | 3 |
translational initiation | 3 |
duced demyelination | 3 |
bcv antigens | 3 |
hiv antibodies | 3 |
vesicular stomatltis | 3 |
viral agents | 3 |
exposure period | 3 |
target concentration | 3 |
chronic disease | 3 |
dna amplified | 3 |
two overlapping | 3 |
nonpolar solvents | 3 |
apparent molecular | 3 |
ion fluxes | 3 |
higher eukaryotes | 3 |
immature vesicle | 3 |
radiation dosage | 3 |
direct action | 3 |
codon intervals | 3 |
infection control | 3 |
study start | 3 |
per gram | 3 |
mm naci | 3 |
nylon fiber | 3 |
bovine herpesvirus | 3 |
worst clinical | 3 |
sperm morphology | 3 |
molecules may | 3 |
one aqueous | 3 |
rna sequence | 3 |
dendritic cells | 3 |
humoral immunity | 3 |
glycoprotein el | 3 |
viral dna | 3 |
fraction ii | 3 |
significantly depressed | 3 |
bp upstream | 3 |
plasmid contains | 3 |
reference reagents | 3 |
infected cell | 3 |
five male | 3 |
preparative therapy | 3 |
methemoglobin levels | 3 |
pooled suspensions | 3 |
animals within | 3 |
cognate trna | 3 |
england journal | 3 |
first position | 3 |
serum antibody | 3 |
atp levels | 3 |
one control | 3 |
specific antibody | 3 |
acute hepatitis | 3 |
labeled probe | 3 |
virus glycoprotein | 3 |
quite rapid | 3 |
terminal euthanasia | 3 |
methylene chloride | 3 |
values represent | 3 |
laboratory rodents | 3 |
free medium | 3 |
flanking sequences | 3 |
movement may | 3 |
dna sequencing | 3 |
trans half | 3 |
oligonucleotides containing | 3 |
multiple trauma | 3 |
also called | 3 |
seropositive patients | 3 |
bamhl sites | 3 |
angiotensinogen synthesis | 3 |
host system | 3 |
oral immune | 3 |
specific antigen | 3 |
differential hydrolysis | 3 |
region coding | 3 |
linked oligosaccharides | 3 |
dotted line | 3 |
research complications | 3 |
high concentrations | 3 |
membrane interactions | 3 |
porcine respiratory | 3 |
influenza ha | 3 |
linked glycosylation | 3 |
preincubation time | 3 |
see table | 3 |
animals poisoned | 3 |
effective prophylaxis | 3 |
isolated using | 3 |
antisense mrna | 3 |
escherichia coll | 3 |
lacz fusion | 3 |
rabbit igg | 3 |
fragment encompassing | 3 |
event occurs | 3 |
peroxy compound | 3 |
lactogenic protection | 3 |
apparatus may | 3 |
dependent manner | 3 |
pathogenic potential | 3 |
membrane integration | 3 |
active hcmv | 3 |
studies reported | 3 |
fusion activity | 3 |
six patients | 3 |
microbial agents | 3 |
doubling time | 3 |
neuropeptide processing | 3 |
controlled studies | 3 |
different amounts | 3 |
lower levels | 3 |
whitney test | 3 |
dhfr polypeptides | 3 |
possibly due | 3 |
higher exposure | 3 |
hepatic angiotensinogen | 3 |
new clsternae | 3 |
nineteen patients | 3 |
fungal rhinitis | 3 |
studies indicate | 3 |
plus mm | 3 |
mg dl | 3 |
asialoglycoprotein receptor | 3 |
preliminary experiments | 3 |
dna probe | 3 |
results obtained | 3 |
cmv infection | 3 |
binding protein | 3 |
virus strains | 3 |
type levels | 3 |
due either | 3 |
muscle fibers | 3 |
potentially pathogenic | 3 |
frame termination | 3 |
ml dose | 3 |
first week | 3 |
toxin treatment | 3 |
slippery run | 3 |
widely used | 3 |
recognition particle | 3 |
control region | 3 |
unirradiated mice | 3 |
significant inactivation | 3 |
sheep kidney | 3 |
sugar unit | 3 |
capsid protein | 3 |
northern blots | 3 |
nm colloidal | 3 |
apgar scores | 3 |
cell peptides | 3 |
aplysia californica | 3 |
specific monoclonal | 3 |
mm na | 3 |
dhfr chain | 3 |
apparatus structures | 3 |
animal viruses | 3 |
low incidence | 3 |
serum iga | 3 |
clearly demonstrated | 3 |
prohormone processing | 3 |
lane i | 3 |
slippage model | 3 |
prcv infection | 3 |
net effect | 3 |
liver rna | 3 |
uranyl acetate | 3 |
relative standard | 3 |
translocation process | 3 |
six leucine | 3 |
acid acetone | 3 |
dead cells | 3 |
surface antigens | 3 |
monensln block | 3 |
weight loss | 3 |
unique narl | 3 |
inhalation toxicity | 3 |
mononucl es | 3 |
monensln may | 3 |
one additional | 3 |
carcinogenicity studies | 3 |
statistical analyses | 3 |
na cacodylate | 3 |
following induction | 3 |
early antigen | 3 |
carbohydrate chains | 3 |
micellar media | 3 |
kg every | 3 |
osmotically active | 3 |
uracil residues | 3 |
associated respiratory | 3 |
monensln treatment | 3 |
table iii | 3 |
primarily associated | 3 |
equine species | 3 |
single gene | 3 |
research institute | 3 |
liter min | 3 |
compare lanes | 3 |
line represents | 3 |
encephalitis virus | 3 |
extremely important | 3 |
ascitic fluids | 3 |
mouse dihydrofolate | 3 |
murine respiratory | 3 |
viral transmission | 2 |
often exerted | 2 |
contains one | 2 |
pathogenic role | 2 |
results showed | 2 |
usually associated | 2 |
month old | 2 |
organ weight | 2 |
administered ivig | 2 |
directed mutagenesis | 2 |
trans compartments | 2 |
although lesions | 2 |
workers reported | 2 |
bacterial autolysates | 2 |
urinary enzymes | 2 |
producing ifn | 2 |
processing step | 2 |
arrow points | 2 |
normal membrane | 2 |
also indicated | 2 |
transplantation patients | 2 |
including viruses | 2 |
rna contains | 2 |
subclinical infection | 2 |
direct transfer | 2 |
complexes na | 2 |
rat ovarian | 2 |
health sciences | 2 |
ii cell | 2 |
mixed inflammatory | 2 |
animal golgl | 2 |
foreign compounds | 2 |
cytoplasmic membrane | 2 |
rna sequences | 2 |
affinity chromatography | 2 |
onto uua | 2 |
simple method | 2 |
either rats | 2 |
hybrid protein | 2 |
nucleotides upstream | 2 |
artificial sea | 2 |
membrane extensions | 2 |
time required | 2 |
arg codon | 2 |
induced disease | 2 |
gamed wide | 2 |
plasmid dna | 2 |
qualitatively similar | 2 |
days postinfection | 2 |
also known | 2 |
translocator protein | 2 |
gene derived | 2 |
macrophage activation | 2 |
aminoterminal sequence | 2 |
graft versus | 2 |
antigenic variant | 2 |
pilot study | 2 |
left untreated | 2 |
aminoglycoside antibiotics | 2 |
two studies | 2 |
saccharomyces cerevisiae | 2 |
rapidly cleared | 2 |
mottled dcvs | 2 |
glycoprotein gill | 2 |
outer segments | 2 |
negative viral | 2 |
two higher | 2 |
hepatocyte vacuolation | 2 |
understood mechanisms | 2 |
control peptide | 2 |
sixteen live | 2 |
mice following | 2 |
direct evidence | 2 |
second phase | 2 |
containing mm | 2 |
high doses | 2 |
perivascular cuffing | 2 |
much greater | 2 |
lower row | 2 |
quality diagnostic | 2 |
chain release | 2 |
laboratory diagnosis | 2 |
gastrointestinal disease | 2 |
also made | 2 |
rat exposed | 2 |
culture adapted | 2 |
elements employ | 2 |
nucleic acids | 2 |
inhibits frameshifting | 2 |
virus antigens | 2 |
week exposure | 2 |
bp frameshift | 2 |
significantly lower | 2 |
proton pump | 2 |
transferred cells | 2 |
helical hairpin | 2 |
oral kanamycin | 2 |
respiratory infections | 2 |
uua leucine | 2 |
body fluids | 2 |
nonparametric samples | 2 |
acute infections | 2 |
amber suppressor | 2 |
one part | 2 |
cell growth | 2 |
relatively small | 2 |
viral cytopathic | 2 |
unlabeled large | 2 |
support frameshifting | 2 |
also allow | 2 |
structures appear | 2 |
cleavage site | 2 |
aminoterminal intermediate | 2 |
eastern equine | 2 |
apparently normal | 2 |
maximum sensitivity | 2 |
administered local | 2 |
abundance trnas | 2 |
biological products | 2 |
statistical significance | 2 |
otitis media | 2 |
time intervals | 2 |
high titers | 2 |
suppressor cells | 2 |
encoded structural | 2 |
sequence conserved | 2 |
autoradiography high | 2 |
chicken embryo | 2 |
two samples | 2 |
term stability | 2 |
translational reading | 2 |
great commercial | 2 |
htpiirtpi antibodies | 2 |
lysosomal proteins | 2 |
chronically infected | 2 |
related compartments | 2 |
uuu codon | 2 |
contain dense | 2 |
haploid yeast | 2 |
terminal bag | 2 |
gas formation | 2 |
specific proteins | 2 |
essential nucleotides | 2 |
antigen potency | 2 |
experimental infections | 2 |
first observed | 2 |
rough endoplasmic | 2 |
acetic acid | 2 |
lymphoblastoid cell | 2 |
liver samples | 2 |
pituitary gland | 2 |
clin immunol | 2 |
driven proton | 2 |
glycoprotein glii | 2 |
stacked clsternae | 2 |
care unit | 2 |
reovirus types | 2 |
data indicate | 2 |
clinical disease | 2 |
gamma treatment | 2 |
galactosidase production | 2 |
cytotoxin sequence | 2 |
coli case | 2 |
diphtheria toxin | 2 |
multiply traumatized | 2 |
profound effects | 2 |
sarcoma virus | 2 |
dr cells | 2 |
signal hypothesis | 2 |
mass median | 2 |
mammalian cells | 2 |
severe toxicological | 2 |
complete set | 2 |
swollen matochondrm | 2 |
monensm effect | 2 |
ha tests | 2 |
temporal clustering | 2 |
increasing amounts | 2 |
virus suspensions | 2 |
blood sampling | 2 |
pst i | 2 |
mouse thymocytes | 2 |
monensin concentrations | 2 |
completely abolished | 2 |
monthly intervals | 2 |
hydrophobic region | 2 |
seropositive donor | 2 |
plus etoh | 2 |
matrix protein | 2 |
coded proteins | 2 |
radial immunodiffusion | 2 |
retrotransposon ty | 2 |
expression strategies | 2 |
ifn yields | 2 |
antisense angiotensinogen | 2 |
kda sl | 2 |
three patients | 2 |
additional amino | 2 |
harderian gland | 2 |
particularly susceptible | 2 |
nucleotide immediately | 2 |
ionophores polyether | 2 |
sugar units | 2 |
feeding seemed | 2 |
cmv interstitial | 2 |
mycoplasma membranes | 2 |
bronchiolar epithelial | 2 |
myelinating disease | 2 |
codon recognized | 2 |
response within | 2 |
intermediate condenses | 2 |
vesicles appear | 2 |
following exposure | 2 |
cellular effects | 2 |
expression vector | 2 |
statistical evaluation | 2 |
philips electronic | 2 |
hybridoma culture | 2 |
length rat | 2 |
concentrations less | 2 |
les cellules | 2 |
times higher | 2 |
formula feeding | 2 |
aplastic anemia | 2 |
disease processes | 2 |
indicates nylon | 2 |
nonspecific nephrotoxicity | 2 |
context effects | 2 |
sac i | 2 |
daily means | 2 |
systemic hypoxia | 2 |
two patients | 2 |
final dilution | 2 |
found exclusively | 2 |
related changes | 2 |
following monensin | 2 |
clinical isolates | 2 |
ovarian granulosa | 2 |
partial rna | 2 |
carcinogenic responses | 2 |
many incompletely | 2 |
result may | 2 |
protein nucleotide | 2 |
restriction endonucleases | 2 |
activated plasma | 2 |
purified cloned | 2 |
express acz | 2 |
sorting event | 2 |
structural analysis | 2 |
rna hybridization | 2 |
muscle weakness | 2 |
early genes | 2 |
certain endosomes | 2 |
one side | 2 |
full length | 2 |
neonatal rats | 2 |
protein binding | 2 |
least three | 2 |
average area | 2 |
developmental regulation | 2 |
chromosomal dna | 2 |
hiv antibody | 2 |
toxin appears | 2 |
occurs despite | 2 |
clsternae observed | 2 |
significantly less | 2 |
residues apart | 2 |
disease history | 2 |
mouse cells | 2 |
also blocked | 2 |
lacrimal glands | 2 |
hiv positive | 2 |
experimental carcinogenesis | 2 |
protein secretion | 2 |
immune responses | 2 |
abnormal effects | 2 |
first two | 2 |
sperm density | 2 |
inactivated antigens | 2 |
chemical inactivation | 2 |
slower migrating | 2 |
ebv negative | 2 |
percentage piglet | 2 |
containing vesicles | 2 |
ph optimum | 2 |
secretory protein | 2 |
cellular receptors | 2 |
codon inhibits | 2 |
golgi region | 2 |
glycosylated early | 2 |
minute volume | 2 |
several important | 2 |
hr exposure | 2 |
nonspecific airway | 2 |
acetone extraction | 2 |
endosome function | 2 |
may still | 2 |
mucous membranes | 2 |
natural killer | 2 |
inflammatory reactions | 2 |
suppressor trna | 2 |
complete nucleotide | 2 |
contractile vacuoles | 2 |
trypsin contained | 2 |
nasal passages | 2 |
workers exposed | 2 |
cored vesicles | 2 |
involuntary movements | 2 |
pseudorabies virus | 2 |
induced injury | 2 |
signals significantly | 2 |
sows infected | 2 |
abdominal ganglion | 2 |
labeled probes | 2 |
four months | 2 |
acz fragment | 2 |
histological score | 2 |
causes demyelination | 2 |
mycoplasma pulmonis | 2 |
regulatory regions | 2 |
inflammatory changes | 2 |
important murine | 2 |
distribution patterns | 2 |
hbs antigen | 2 |
molecular biology | 2 |
radiation source | 2 |
ebv infected | 2 |
polyacrylamide gels | 2 |
higher concentrations | 2 |
became excretors | 2 |
intestinal gas | 2 |
experiments involved | 2 |
mouse strain | 2 |
yeast genome | 2 |
linked carbohydrate | 2 |
detection level | 2 |
mutagenesis data | 2 |
ice bath | 2 |
structural polyprotein | 2 |
gradient centrifugation | 2 |
varying concentrations | 2 |
given second | 2 |
two genes | 2 |
cleaved molecules | 2 |
foreign population | 2 |
earliest time | 2 |
satisfactory potency | 2 |
must occur | 2 |
might result | 2 |
distinct class | 2 |
derived radicals | 2 |
four specimens | 2 |
receptor protein | 2 |
within one | 2 |
chains appear | 2 |
essentially identical | 2 |
nuclear protein | 2 |
newborn lambs | 2 |
positive bacteria | 2 |
animal experiments | 2 |
various immune | 2 |
experimental tool | 2 |
probably accounts | 2 |
investigate whether | 2 |
human immunodeficiency | 2 |
standard therapy | 2 |
deletion analysis | 2 |
unhybridized probe | 2 |
wild type | 2 |
genomic organization | 2 |
observed monensin | 2 |
yeast phenylalanine | 2 |
human papillomaviruses | 2 |
versus host | 2 |
hepatitis viruses | 2 |
remained stable | 2 |
carcinogenesis studies | 2 |
stable membrane | 2 |
four times | 2 |
swelling response | 2 |
protein translocation | 2 |
occurs shortly | 2 |
barr virus | 2 |
lesions observed | 2 |
xmn i | 2 |
pbmc supernatants | 2 |
coat proteins | 2 |
residue fragment | 2 |
two weak | 2 |
sheep liver | 2 |
immune reaction | 2 |
pal genes | 2 |
hairpin hypothesis | 2 |
first cleavage | 2 |
cycle length | 2 |
endoplasmlc reticulum | 2 |
pg ml | 2 |
estrous cycle | 2 |
rod outer | 2 |
well microtiter | 2 |
per dilution | 2 |
predictable pattern | 2 |
present time | 2 |
antiviral activity | 2 |
structural gene | 2 |
administered antibodies | 2 |
evidence suggests | 2 |
second set | 2 |
ifn activity | 2 |
allow frameshifting | 2 |
infected rats | 2 |
culture tubes | 2 |
four nucleotides | 2 |
typespecific antibodies | 2 |
intracellular degradation | 2 |
fully activated | 2 |
protein complex | 2 |
central vacuole | 2 |
dm mdqhl | 2 |
small number | 2 |
remaining neuraminidase | 2 |
often occurred | 2 |
seventh base | 2 |
detect hiv | 2 |
least twice | 2 |
virus neuraminidase | 2 |
patients remained | 2 |
established cmv | 2 |
similar lesions | 2 |
also support | 2 |
per micrometer | 2 |
cd cells | 2 |
ascites cells | 2 |
translocated chain | 2 |
inward movement | 2 |
amersham corp | 2 |
mm kci | 2 |
protein occurs | 2 |
neuropeptides derived | 2 |
large numbers | 2 |
cow anterior | 2 |
stressed low | 2 |
tgev antibodies | 2 |
biolumat lb | 2 |
experimental allergic | 2 |
serous salivary | 2 |
per milliliter | 2 |
nec occurred | 2 |
four codons | 2 |
enzyme release | 2 |
viruses grown | 2 |
terminal final | 2 |
stillborn piglets | 2 |
embryonated chicken | 2 |
frame uag | 2 |
binding activity | 2 |
group developed | 2 |
image following | 2 |
free nh | 2 |
golgx apparatus | 2 |
showed less | 2 |
positive infections | 2 |
significantly different | 2 |
cell hyperplasia | 2 |
pulmonary lesions | 2 |
monensm may | 2 |
much lower | 2 |
dried gel | 2 |
polyclonal antibodies | 2 |
significantly greater | 2 |
transfer model | 2 |
induced swelling | 2 |
novel anticodons | 2 |
numerous respiratory | 2 |
without significant | 2 |
aerodynamic diameter | 2 |
separated granulocytes | 2 |
multiple neuropeptides | 2 |
sacl acz | 2 |
different strains | 2 |
room temperature | 2 |
tyrosine codon | 2 |
plants vs | 2 |
liver enzymes | 2 |
experimentally infected | 2 |
will cause | 2 |
granulosa cells | 2 |
past hsv | 2 |
ester linked | 2 |
phosphatase reaction | 2 |
net salt | 2 |
following treatment | 2 |
labeled anti | 2 |
green alga | 2 |
united states | 2 |
ca stores | 2 |
swine leukocyte | 2 |
dna modifications | 2 |
decode cuu | 2 |
env gene | 2 |
uninfected hrt | 2 |
strain variability | 2 |
secretory activity | 2 |
medium supplemented | 2 |
considerable amounts | 2 |
sacl laczfragment | 2 |
human cytomegalovirus | 2 |
abnormal postures | 2 |
bf gq | 2 |
tissue origin | 2 |
apgar score | 2 |
formed within | 2 |
medium containing | 2 |
coding capacity | 2 |
membrane structures | 2 |
hybridization assay | 2 |
rectal tumor | 2 |
radiation exposure | 2 |
experimental infection | 2 |
normally provided | 2 |
tya reading | 2 |
autologous ebv | 2 |
nascent immunoglobin | 2 |
hav titers | 2 |
electronic instruments | 2 |
per week | 2 |
control experiments | 2 |
ak bf | 2 |
human flbroblasts | 2 |
eggs inoculated | 2 |
osmotic uptake | 2 |
lymphohematopoietic function | 2 |
frameshifting signal | 2 |
cmv infections | 2 |
channel biolumat | 2 |
control measures | 2 |
cellules infect | 2 |
cells induced | 2 |
one apparent | 2 |
deduced sequence | 2 |
bronchoalveolar lavage | 2 |
sequential appearance | 2 |
present address | 2 |
acetylesterase activity | 2 |
performed according | 2 |
infected fibroblasts | 2 |
iga antibodies | 2 |
tissues taken | 2 |
membrane structure | 2 |
inverted repeat | 2 |
acid compartments | 2 |
igg subclasses | 2 |
blot analyses | 2 |
migrated clearly | 2 |
beyond day | 2 |
effective replacement | 2 |
animals exposed | 2 |
generally observed | 2 |
normal rabbit | 2 |
lon complex | 2 |
prevent internalization | 2 |
maintenance medium | 2 |
chain termination | 2 |
produce ifn | 2 |
azodicarbonamide use | 2 |
may show | 2 |
may exist | 2 |
cavity may | 2 |
major viral | 2 |
renal lesions | 2 |
six embryonated | 2 |
workers found | 2 |
without ata | 2 |
antibodies specific | 2 |
per ml | 2 |
cell function | 2 |
cardiac output | 2 |
acetylcholinesterase activities | 2 |
free energy | 2 |
receptor sites | 2 |
differential irradiation | 2 |
resident macrophages | 2 |
immunofluorescence microscopy | 2 |
ha titers | 2 |
cmv seronegative | 2 |
significant increase | 2 |
safe method | 2 |
oxygen species | 2 |
rats died | 2 |
ionophore monensin | 2 |
myocardial damage | 2 |
direct frameshifting | 2 |
toxicological manifestations | 2 |
virus inactivation | 2 |
immune splenocytes | 2 |
often associated | 2 |
host cells | 2 |
abundant trna | 2 |
infected glutaraldehyde | 2 |
considerably lower | 2 |
cisternae per | 2 |
anecdotal evidence | 2 |
sequence data | 2 |
goat anti | 2 |
virus assembly | 2 |
cellular immunity | 2 |
rats given | 2 |
internalized ligands | 2 |
transient expression | 2 |
pulse rate | 2 |
igg fraction | 2 |
takes place | 2 |
cellules productrices | 2 |
oncogenic potential | 2 |
different regions | 2 |
preparing diagnostic | 2 |
diarrhea caused | 2 |
fungal growth | 2 |
membrane physiology | 2 |
randomly assigned | 2 |
resolution autoradiography | 2 |
deprived piglet | 2 |
expression unit | 2 |
mediates primarily | 2 |
dependent inhibition | 2 |
fetal spleen | 2 |
multiple sclerosis | 2 |
animal care | 2 |
early postengraftment | 2 |
virus core | 2 |
pore formation | 2 |
salt uptake | 2 |
via yet | 2 |
ionic exchange | 2 |
clear vesicle | 2 |
two years | 2 |
reciprocal titres | 2 |
human adenovirus | 2 |
viral coat | 2 |
allowed cloning | 2 |
mycoplasrna pulmonis | 2 |
mean clinical | 2 |
studies using | 2 |
directionality oligonucleotides | 2 |
including spleen | 2 |
urine samples | 2 |
xhol fragment | 2 |
rats inoculated | 2 |
aerosol monitor | 2 |
cd receptor | 2 |
antibody response | 2 |
severe gastrointestinal | 2 |
initial experiments | 2 |
diarrhoea days | 2 |
standard protocols | 2 |
angiotensinogen messenger | 2 |
glycosylation event | 2 |
cause significant | 2 |
human spumaretrovirus | 2 |
clostridium botulinum | 2 |
oral ig | 2 |
increased nonlinearly | 2 |
uk field | 2 |
marked swelling | 2 |
total time | 2 |
osmium tetroxade | 2 |
increasing ada | 2 |
physiology resulting | 2 |
kpnl linker | 2 |
several days | 2 |
edna fusion | 2 |
state levels | 2 |
electrophoretic mobility | 2 |
toxicity testing | 2 |
nonneutralizing mab | 2 |
year inhalation | 2 |
cell prohormone | 2 |
african green | 2 |
replicated dna | 2 |
solid line | 2 |
containing less | 2 |
given splenocytes | 2 |
aprotic solvents | 2 |
peptide sequence | 2 |
mu fl | 2 |
vesicular stomatitis | 2 |
cultured animal | 2 |
cloned complementary | 2 |
new band | 2 |
split samples | 2 |
plant golgl | 2 |
virus protein | 2 |
recent report | 2 |
secretory product | 2 |
related sequences | 2 |
translational frameshifting | 2 |
laboratory effluent | 2 |
consensus features | 2 |
intranasal alpha | 2 |
viral diagnostic | 2 |
particle size | 2 |
rite transmissible | 2 |
first described | 2 |
term storage | 2 |
mice died | 2 |
virus infected | 2 |
receptor expression | 2 |
angiotensinogen rna | 2 |
tgev inoculated | 2 |
liquid chromatography | 2 |
transport vesicles | 2 |
first codons | 2 |
chnlcal manifestations | 2 |
seasonal peaks | 2 |
neutralizing antibodies | 2 |
bound receptor | 2 |
determined using | 2 |
transfer process | 2 |
igg subclass | 2 |
noncoding region | 2 |
well described | 2 |
translocation site | 2 |
context effect | 2 |
focal dystonias | 2 |
jhm virus | 2 |
data demonstrate | 2 |
cells reduced | 2 |
repeated inhalation | 2 |
encoded virus | 2 |
specific antibodies | 2 |
size heterogeneity | 2 |
neonatal calf | 2 |
containing carboxy | 2 |
acute pancreatitis | 2 |
improvement may | 2 |
experimentally induced | 2 |
secretory materials | 2 |
humoral immune | 2 |
disease course | 2 |
golgi stack | 2 |
large phe | 2 |
labeled cytotoxin | 2 |
prelysosomal compartments | 2 |
mean ada | 2 |
rodent infectious | 2 |
also observed | 2 |
receptor capping | 2 |
prime synthesis | 2 |
incubated overnight | 2 |
endothelial structures | 2 |
filtered air | 2 |
ty element | 2 |
large amounts | 2 |
consistently positive | 2 |
late postengraftment | 2 |
antig nes | 2 |
additional clsterna | 2 |
reporter hybrid | 2 |
shifty trna | 2 |
disease caused | 2 |
probe assay | 2 |
thymidine kinase | 2 |
experiments revealed | 2 |
airway injury | 2 |
sperm count | 2 |
small percentage | 2 |
examined histologically | 2 |
increased levels | 2 |
became available | 2 |
translation initiation | 2 |
ribonucleic acids | 2 |
precursor protein | 2 |
primes synthesis | 2 |
large granular | 2 |
trade names | 2 |
infected hrt | 2 |
culture medium | 2 |
influenza reagents | 2 |
animal studies | 2 |
region confers | 2 |
adult rats | 2 |
specific iga | 2 |
associated elements | 2 |
reticulum membrane | 2 |
tata box | 2 |
galactosidase purification | 2 |
washed four | 2 |
human rectal | 2 |
also occur | 2 |
also seen | 2 |
different ph | 2 |
week exposures | 2 |
pathway bypassing | 2 |
satisfactory results | 2 |
allantoic fluid | 2 |
using specific | 2 |
adult sheep | 2 |
primed neutrophils | 2 |
active cations | 2 |
chase experiment | 2 |
cell count | 2 |
three antigen | 2 |
subsequent cleavages | 2 |
passive immunization | 2 |
experimental animals | 2 |
recombinant vaccinia | 2 |
blocks transport | 2 |
independent transcription | 2 |
jcv tantigen | 2 |
sequence defined | 2 |
geometric standard | 2 |
small amino | 2 |
research council | 2 |
without trypsin | 2 |
high values | 2 |
isoaccepting species | 2 |
allow lower | 2 |
combined signal | 2 |
detailed clinical | 2 |
tympanic cavity | 2 |
functional activity | 2 |
interferon production | 2 |
yet poorly | 2 |
green monkey | 2 |
labeled immature | 2 |
venezuelan equine | 2 |
potassium permanganate | 2 |
hybridization protection | 2 |
immune complexes | 2 |
first day | 2 |
tumour cells | 2 |
laboratory strains | 2 |
cells failed | 2 |
fetal calf | 2 |
multifocal type | 2 |
paper attempts | 2 |
alpha bag | 2 |
sows successfully | 2 |
whereas alveolar | 2 |
intranasal interferon | 2 |
increase myocardial | 2 |
therapeutic use | 2 |
two litters | 2 |
simian rotavirus | 2 |
epithelial hyperplasias | 2 |
viral infectivity | 2 |
clinilumat lb | 2 |
piglets sucking | 2 |
may protect | 2 |
type specific | 2 |
apparatus based | 2 |
olfactory epithelium | 2 |
human peripheral | 2 |
ganglionic infection | 2 |
dna gave | 2 |
cellules mononucl | 2 |
last trimester | 2 |
precursor may | 2 |
proton gradient | 2 |
dissipate cation | 2 |
vector system | 2 |
robert weiss | 2 |
much higher | 2 |
occur within | 2 |
cell biology | 2 |
trna decoding | 2 |
monensln toxlcosls | 2 |
crystalline compound | 2 |
aqueous solution | 2 |
following incubation | 2 |
extent cd | 2 |
shuttle vesicles | 2 |
additional step | 2 |
different sets | 2 |
twin birth | 2 |
may reflect | 2 |
indicated time | 2 |
underlying mode | 2 |
less toxic | 2 |
observations suggest | 2 |
disease virus | 2 |
first aug | 2 |
pneumonia virus | 2 |
fragment containing | 2 |
functionally distinct | 2 |
viral gil | 2 |
inactivation procedures | 2 |
negative control | 2 |
ivig orally | 2 |
blood flow | 2 |
hbs specific | 2 |
ifn yield | 2 |
mean liver | 2 |
primary antibody | 2 |
anticodon uag | 2 |
rhesus monkey | 2 |
given systemically | 2 |
poorly understood | 2 |
frame uuu | 2 |
enteric microorganisms | 2 |
different compartments | 2 |
posttraumatic course | 2 |
secreted via | 2 |
infect es | 2 |
less inactivation | 2 |
monensin experiment | 2 |
significant alterations | 2 |
tonb protein | 2 |
becomes glycosylated | 2 |
ross river | 2 |
chemiluminescent system | 2 |
jhmv infection | 2 |
altered ion | 2 |
prevalent murine | 2 |
xk yuibj | 2 |
immune spleen | 2 |
sows inoculated | 2 |
mouse coronavirus | 2 |
hybrid molecule | 2 |
cells showed | 2 |
protease resistance | 2 |
net influx | 2 |
growth factor | 2 |
octamer linker | 2 |
virus structural | 2 |
tgev inoculations | 2 |
cytotoxic protein | 2 |
strains indicated | 2 |
might also | 2 |
serum albumin | 2 |
biomedical research | 2 |
small arrow | 2 |
acceptor peptide | 2 |
became depressed | 2 |
eukaryotes occurs | 2 |
cascade impactor | 2 |
positive organisms | 2 |
rat angiotensinogen | 2 |
enhanced cell | 2 |
like cellular | 2 |
intestinal flora | 2 |
yeast retrotransposon | 2 |
protein variant | 2 |
week inhalation | 2 |
severe ibr | 2 |
derived bands | 2 |
adventitious murine | 2 |
van nieuwstadt | 2 |
significant amount | 2 |
expressing cell | 2 |
ten times | 2 |
gut homogenate | 2 |
confirmatory test | 2 |
extensive destruction | 2 |
plasma renin | 2 |
microflora reservoirs | 2 |
cell immunity | 2 |
phenomena caused | 2 |
monocistronic mrna | 2 |
growth hormone | 2 |
males given | 2 |
globulin preparations | 2 |
exposure day | 2 |
see materials | 2 |
secondary phenomena | 2 |
frameshift within | 2 |
proteolytic activation | 2 |
located upstream | 2 |
isolated tissues | 2 |
years benefited | 2 |
trans face | 2 |
minimal medium | 2 |
randomly distributed | 2 |
mm nacl | 2 |
higher doses | 2 |
changes allow | 2 |
guanidinium isothiocyanate | 2 |
murine cells | 2 |
optical density | 2 |
open question | 2 |
without knowledge | 2 |
kda precursor | 2 |
slippage method | 2 |
gamma globulin | 2 |
apparatus adjacent | 2 |
preventing cmv | 2 |
fixation solution | 2 |
neutralizing mab | 2 |
seven days | 2 |
semlikl forest | 2 |
contains also | 2 |
protein trafficking | 2 |
epidermodysplasia verruciformis | 2 |
mammalian retroviral | 2 |
acid solution | 2 |
way analysis | 2 |
tissue shces | 2 |
log dilutions | 2 |
subsequent autoradiography | 2 |
cell strains | 2 |
barley aleurone | 2 |
intracellular processing | 2 |
rat hepatocytes | 2 |
carboxyterminal intermediate | 2 |
maximum likelihood | 2 |
chimpanzee alpha | 2 |
hjc cells | 2 |
cells without | 2 |
see whether | 2 |
strongly visible | 2 |
site three | 2 |
specific amplification | 2 |
unpubhshed data | 2 |
demyelination induced | 2 |
min apgar | 2 |
codon substitutions | 2 |
born piglets | 2 |
earlier time | 2 |
trans cisternae | 2 |
given virus | 2 |
myocardial function | 2 |
informed consent | 2 |
state university | 2 |
common effect | 2 |
secondary effects | 2 |
single isoacceptor | 2 |
reaction kinetics | 2 |
stomatitis virus | 2 |
induced cell | 2 |
polar environment | 2 |
positive donors | 2 |
histologic examination | 2 |
cheng el | 2 |
pseudomonas aerugmosa | 2 |
caudal tissue | 2 |
involving acid | 2 |
clearly visible | 2 |
target cells | 2 |
highly dependent | 2 |
infected monolayers | 2 |
cells may | 2 |
apparent lack | 2 |
codon substitution | 2 |
fragments jl | 2 |
uncleaved signal | 2 |
fungal infection | 2 |
one week | 2 |
inactivated reagents | 2 |
apparent consequence | 2 |
critical role | 2 |
infected bhk | 2 |
traffic involving | 2 |
vaccinia virus | 2 |
monensintreated cells | 2 |
subcellular sites | 2 |
treatment groups | 2 |
gag frame | 2 |
viral enteritis | 2 |
roi production | 2 |
i linker | 2 |
murine hepatitis | 2 |
chicken eggs | 2 |
frameshifting seen | 2 |
schwarz pharma | 2 |
complementary dna | 2 |
ligands may | 2 |
prcv seropositive | 2 |
count elf | 2 |
lesions induced | 2 |
fundamentally different | 2 |
isolated cells | 2 |
alone causes | 2 |
antibody production | 2 |
hd values | 2 |
mab plus | 2 |
lungs increased | 2 |
relevant pth | 2 |
sall site | 2 |
apparatus elements | 2 |
maize root | 2 |
toxicologic studies | 2 |
percoll gradient | 2 |
respective scores | 2 |
lung section | 2 |
coronavirus jhm | 2 |
apparatus region | 2 |
animals fed | 2 |
antigen expression | 2 |
system oxalic | 2 |
early stage | 2 |
peroxyoxalate chemiluminescence | 2 |
regulated release | 2 |
deletion constructs | 2 |
human services | 2 |
yeast genes | 2 |
monensin affects | 2 |
terminal side | 2 |
also done | 2 |
likely due | 2 |
river virus | 2 |
main source | 2 |
electron microscopic | 2 |
immunohistochemical staining | 2 |
least one | 2 |
immunosuppressed patients | 2 |
apparatus membranes | 2 |
several risk | 2 |
inactivation experiments | 2 |
monensln effects | 2 |
amino terminus | 2 |
ig concentration | 2 |
total volume | 2 |
related lesions | 2 |
monensm inhibited | 2 |
ada concentration | 2 |
tightly regulated | 2 |
mature sheep | 2 |
studies showed | 2 |
air concentrations | 2 |
rabies vaccines | 2 |
least two | 2 |
second trna | 2 |
stomatltis virus | 2 |
metal ions | 2 |
transmembrane exchange | 2 |
lysis assay | 2 |
prevents jhmv | 2 |
bnlfi protein | 2 |
codon immediately | 2 |
respiratory system | 2 |
monensln resulted | 2 |
unknown hiv | 2 |
lnduced swelhng | 2 |
acidic intracellular | 2 |
efficient utilization | 2 |
kidney rna | 2 |
tgev neutralizing | 2 |
given rad | 2 |
nasal lesions | 2 |
two features | 2 |
bpl inactivation | 2 |
significant lesions | 2 |
kidney also | 2 |
organ weights | 2 |
serum ig | 2 |
secondary response | 2 |
ifn inducers | 2 |
rf gene | 2 |
globulin therapy | 2 |
mean air | 2 |
gal fusion | 2 |
cells using | 2 |
activated granulocytes | 2 |
bind calcium | 2 |
understood although | 2 |
identical nucleotides | 2 |
related viruses | 2 |
immunol doi | 2 |
tract lesions | 2 |
significant difference | 2 |
microscopic pathology | 2 |
processing enzymes | 2 |
seven translations | 2 |
activated cells | 2 |
vitro models | 2 |
contain acid | 2 |
almost predictable | 2 |
rabbit antibody | 2 |
intramuscular injection | 2 |
abundant trnas | 2 |
ha antigen | 2 |
small amounts | 2 |
determine whether | 2 |
induced demyelina | 2 |
promote frameshifting | 2 |
canine distemper | 2 |
monospecific antibodies | 2 |
field isolate | 2 |
ppkm virus | 2 |
graded according | 2 |
att cells | 2 |
epithelial hyperplasia | 2 |
hcv carriers | 2 |
also performed | 2 |
transport system | 2 |
symptoms may | 2 |
ty retrotransposons | 2 |
ochre suppressor | 2 |
frame uga | 2 |
among animals | 2 |
infection may | 2 |
type construct | 2 |
neutral ph | 2 |
intensive care | 2 |
specific igg | 2 |
maximum within | 2 |
hsv type | 2 |
mm phe | 2 |
em autoradiographic | 2 |
containing side | 2 |
clinical diagnosis | 2 |
trypsin cleavage | 2 |
dramatically reduced | 2 |
immunosuppressive dose | 2 |
microtitre plates | 2 |
oral exposures | 2 |
relative levels | 2 |
promotes frameshifting | 2 |
early region | 2 |
ivig supplementation | 2 |
susceptible cells | 2 |
collagenase digestion | 2 |
coli serotype | 2 |
greater extent | 2 |
average follow | 2 |
bfs cultures | 2 |
found predominantly | 2 |
response resulting | 2 |
jcj nqfu | 2 |
retroviral pal | 2 |
positive effect | 2 |
lead nitrate | 2 |
rna secondary | 2 |
normal background | 2 |
repeated study | 2 |
two major | 2 |
increased approximately | 2 |
previous studies | 2 |
encapsulated organisms | 2 |
dense cored | 2 |
antigen preparations | 2 |
findings suggest | 2 |
jhmv causes | 2 |
respiratory epithelial | 2 |
pentapeptide consensus | 2 |
two strains | 2 |
acute haemorrhagic | 2 |
proteins ns | 2 |
padilla lugo | 2 |
confirmed anti | 2 |
selective ionophore | 2 |
blocking experiments | 2 |
therapeutic agents | 2 |
cell infiltrate | 2 |
different sites | 2 |
copy essential | 2 |
since neither | 2 |
contain antibodies | 2 |
reference antigens | 2 |
density hpoprotem | 2 |
fraction enriched | 2 |
affected muscles | 2 |
low ph | 2 |
chemical agents | 2 |
trnaarg ccu | 2 |
leucine codon | 2 |
individual samples | 2 |
equine miami | 2 |
immediate early | 2 |
mab th | 2 |
agarose gel | 2 |
reduces frameshifting | 2 |
sequence coding | 2 |
reporter molecules | 2 |
minimal essential | 2 |
result demonstrates | 2 |
escherichia co | 2 |
specific ctls | 2 |
neonatal intensive | 2 |
universal response | 2 |
hydrophilicity profiles | 2 |
drastically reduces | 2 |
related antigenically | 2 |
codon recognition | 2 |
monensin blocks | 2 |
carboxyhc lonophores | 2 |
monensm inhibition | 2 |
swollen mitochondria | 2 |
previously reported | 2 |
piglet faeces | 2 |
immunoperoxidase staining | 2 |
herpes virus | 2 |
plasma cells | 2 |
produce similar | 2 |
radioactive method | 2 |
defined domain | 2 |
granulocyte lysis | 2 |
gg elastase | 2 |
olfactory mucosa | 2 |
vials containing | 2 |
pi transition | 2 |
bechtold el | 2 |
apparatus swelling | 2 |
exit site | 2 |
coli lysates | 2 |
yeast mitochondria | 2 |
dependent monooxygenases | 2 |
cell wall | 2 |
miller strain | 2 |
events occur | 2 |
initiator met | 2 |
northern hybridization | 2 |
observations indicate | 2 |
highly susceptible | 2 |
total translation | 2 |
lewis rats | 2 |
angiotensinogen message | 2 |
noncoding strand | 2 |
western blotting | 2 |
although rats | 2 |
dna polymerase | 2 |
one substituting | 2 |
hantaan nucleocapsid | 2 |
bfs cell | 2 |
triosephosphate isomerase | 2 |
trna encoded | 2 |
test sera | 2 |
human transferrin | 2 |
may play | 2 |
paper reviews | 2 |
already described | 2 |
normal secretory | 2 |
gross necropsy | 2 |
high level | 2 |
yeast strains | 2 |
primary source | 2 |
appreciable levels | 2 |
murine viruses | 2 |
gastrointestinal mucosa | 2 |
infected fixed | 2 |
three tgev | 2 |
videotape recordings | 2 |
cardiac puncture | 2 |
rna intermediate | 2 |
pathological injuries | 2 |
apparatus stacks | 2 |
essential gene | 2 |
ecorv site | 2 |
iggsubclass deficiency | 2 |
poe ep | 2 |
ada aerosols | 2 |
also may | 2 |
increasing exposure | 2 |
particular strain | 2 |
studying golgi | 2 |
blocked cells | 2 |
uua codon | 2 |
systemic effects | 2 |
several different | 2 |
iga igg | 2 |
white muscle | 2 |
virus titer | 2 |
fixed monolayers | 2 |
infective doses | 2 |
neurosecretory peptides | 2 |
frameshifting even | 2 |
must also | 2 |
transferrin receptor | 2 |
traumatized patients | 2 |
mononuclear cell | 2 |
hamster cell | 2 |
aplysia egg | 2 |
proton pumping | 2 |
toxin injection | 2 |
cesarean section | 2 |
see also | 2 |
nb gene | 2 |
ada inhaled | 2 |
piglet diarrhoea | 2 |
vesicles containing | 2 |